Obodence
Obodence is a biosimilar from Samsung Bioepis CH GmbH and is listed on the FOPH Specialities List. As the follow-on product of a biologic it is reimbursed by basic health insurance. The public price ranges from CHF 185.05 to CHF 185.05 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Samsung Bioepis CH GmbH
- ATC code
- M05BX04
- IT group
- 07.99 Varia
- Active substances
- Denosumabum
- Preparation type
- Biosimilar
- On the SL since
- 01/08/2026
- Last price change
- 01/08/2026
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 60 mg/ml m Nadelschutz Fertspr | 1 Stk | CHF 153.90 | CHF 185.05 | 01/08/2026 | B | 7680698730019 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Behandlung der Osteoporose bei postmenopausalen Frauen (Reduktion um mehr als 2,5 Standard-Abweichungen bei der Osteodensitometrie oder bei Fraktur). Begleitbehandlung bei Frauen mit Mammakarzinom unter adjuvanter Behandlung mit Aromatasehemmern und bei Männern mit Prostatakarzinom unter Hormonablation, wenn ein erhöhtes Frakturrisiko vorliegt. Nach Abschluss der adjuvanten Behandlung mit Aromatasehemmern oder der Hormonablation ist auch die Behandlung mit Obodence zu beenden.
Behandlung zur Erhöhung der Knochenmineraldichte bei Männern mit Osteoporose und erhöhtem Frakturrisiko.
More preparations in this group
FAQ
Is Obodence covered by Swiss health insurance?
Yes, but only under conditions. Obodence is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Obodence cost in Switzerland?
The public price is the maximum price set by the FOPH and for Obodence ranges from CHF 185.05 to CHF 185.05 per pack. The ex-factory price ranges from CHF 153.90 to CHF 153.90. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages